LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Marker Therapeutics (NASDAQ: MRKR)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ MRKR Marker Therapeutics
ELMS STEVE / director
12/23/2024
Buy
$3.20
11,085
$35K
325,370
NASDAQ MRKR Marker Therapeutics
New Enterprise Associates 16, L.P. / 10 percent owner
12/23/2024
Buy
$3.20
554,250
$1.774M
1.63M